218 related articles for article (PubMed ID: 23072703)
21. Treatment and survival in diffuse malignant pleural mesothelioma; a study of 83 cases from the Massachusetts General Hospital.
Huncharek M; Kelsey K; Mark EJ; Muscat J; Choi N; Carey R; Christiani D
Anticancer Res; 1996; 16(3A):1265-8. PubMed ID: 8702248
[TBL] [Abstract][Full Text] [Related]
22. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and survival in malignant pleural mesothelioma.
Van Gelder T; Damhuis RA; Hoogsteden HC
Eur Respir J; 1994 Jun; 7(6):1035-8. PubMed ID: 7925870
[TBL] [Abstract][Full Text] [Related]
24. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
Cao KJ; Cui NJ
Ai Zheng; 2005 Jan; 24(1):72-5. PubMed ID: 15642204
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
Rintoul RC; Ritchie AJ; Edwards JG; Waller DA; Coonar AS; Bennett M; Lovato E; Hughes V; Fox-Rushby JA; Sharples LD;
Lancet; 2014 Sep; 384(9948):1118-27. PubMed ID: 24942631
[TBL] [Abstract][Full Text] [Related]
26. Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma.
Chamberlain MH; Fareed K; Nakas A; Martin-Ucar AE; Waller DA
Eur J Cardiothorac Surg; 2008 Jul; 34(1):200-3. PubMed ID: 18450462
[TBL] [Abstract][Full Text] [Related]
27. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
[TBL] [Abstract][Full Text] [Related]
28. Survival of pleural malignant mesothelioma in Italy: a population-based study.
Montanaro F; Rosato R; Gangemi M; Roberti S; Ricceri F; Merler E; Gennaro V; Romanelli A; Chellini E; Pascucci C; Musti M; Nicita C; Barbieri PG; Marinaccio A; Magnani C; Mirabelli D
Int J Cancer; 2009 Jan; 124(1):201-7. PubMed ID: 18792097
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center.
Flores RM; Zakowski M; Venkatraman E; Krug L; Rosenzweig K; Dycoco J; Lee C; Yeoh C; Bains M; Rusch V
J Thorac Oncol; 2007 Oct; 2(10):957-65. PubMed ID: 17909360
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
[TBL] [Abstract][Full Text] [Related]
31. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
[TBL] [Abstract][Full Text] [Related]
32. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
Aelony Y; Yao JF
Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
[TBL] [Abstract][Full Text] [Related]
33. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
[TBL] [Abstract][Full Text] [Related]
34. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy.
Arrossi AV; Lin E; Rice D; Moran CA
Am J Clin Pathol; 2008 Nov; 130(5):754-64. PubMed ID: 18854268
[TBL] [Abstract][Full Text] [Related]
35. Extrapleural pneumonectomy or supportive care: treatment of malignant pleural mesothelioma?
Sharif S; Zahid I; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1040-5. PubMed ID: 21388982
[TBL] [Abstract][Full Text] [Related]
36. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.
Roe OD; Creaney J; Lundgren S; Larsson E; Sandeck H; Boffetta P; Nilsen TI; Robinson B; Kjaerheim K
Lung Cancer; 2008 Aug; 61(2):235-43. PubMed ID: 18281122
[TBL] [Abstract][Full Text] [Related]
37. Tryptase mast cells in malignant pleural mesothelioma as an independent favorable prognostic factor.
Alì G; Boldrini L; Lucchi M; Mussi A; Corsi V; Fontanini G
J Thorac Oncol; 2009 Mar; 4(3):348-54. PubMed ID: 19155997
[TBL] [Abstract][Full Text] [Related]
38. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.
Mineo TC; Ambrogi V; Pompeo E; Baldi A; Stella F; Aurea P; Marino M
Ann Thorac Surg; 2008 May; 85(5):1740-6. PubMed ID: 18442576
[TBL] [Abstract][Full Text] [Related]
39. [Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].
Desoubeaux N; Bouvier V; Gervais R; Galateau-Salle F; Thibon P; Leplumey T; Herbert C; Lecherbonnier Y; Daviet JP; Letourneux M
Rev Epidemiol Sante Publique; 2001 Dec; 49(6):523-9. PubMed ID: 11845101
[TBL] [Abstract][Full Text] [Related]
40. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients.
Ak G; Metintaş M; Yildirim H; Metintaş S; Dündar E; Erginel S; Alataş F
Tuberk Toraks; 2009; 57(1):22-31. PubMed ID: 19533434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]